HCA HCA Healthcare, Inc. Common Stock
NYSE · Health Care · SEC EDGAR पर देखें ↗ बंद अक्ट 2, 2026 10-K/10-Q जुल 28, 2026HCA स्टॉक स्नैपशॉट मूल्य, बाजार पूंजीकरण, P/E, EPS, ROE, ऋण/इक्विटी, 52-सप्ताह की सीमा
HCA स्टॉक मूल्य चार्ट तकनीकी संकेतकों के साथ दैनिक OHLCV — पैन, ज़ूम और अपना दृश्य कस्टमाइज़ करें
बार ग्रैन्युलैरिटी चयनित अवधि के अनुसार अनुकूलित होती है — बार के लिए ओपन/हाई/लो/क्लोज देखने के लिए चार्ट पर होवर करें।
HCA Healthcare, Inc. Common Stock के बारे में विकिपीडिया से कंपनी का अवलोकन
HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.
History
Early years
The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.
The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.
Growth and merger
The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.
In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.
In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,
to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.
Columbia Hospital Corporation
In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.
In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.
Recent history
On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.
In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.
In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.
In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.
In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.
In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.
In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.
In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.
Facilities
United States
As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.
Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.
In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.
In 2019 they purchased Mission Health System which operates hospitals in North Carolina.
In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.
In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.
United Kingdom
HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:
It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.
The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.
The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.
Significant areas of operation
Medical education
In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.
Controversies
Medicare billing practices lawsuit
In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.
The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.
2005 insider trading suit
In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.
COVID-19 PPE
During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.
Mission Hospital Acquisition Complaints
On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.
On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.
स्रोत: विकिपीडिया (अंग्रेज़ी), CC BY-SA 4.0 · विकिपीडिया पर देखें ↗
10-वर्षीय प्रदर्शन राजस्व, शुद्ध आय, मार्जिन और ईपीएस रुझान
मूल्यांकन P/E, P/S, P/B, EV/EBITDA अनुपात — क्या स्टॉक महंगा है या सस्ता?
| मेट्रिक | 5Y रुझान | HCA | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| P/E (TTM) | 14.35Y औसत ≈13.8 | ≈13.8 | 16.5 | अल्पमूल्यित | |
| P/S (TTM) | 1.25Y औसत ≈1.2 | ≈1.2 | 1.2 | उचित मूल्य | |
| P/B (MRQ) | -14.05Y औसत ≈-39.2 | ≈-39.2 | · | · | |
| EV / EBITDA | 38.75Y औसत ≈37.3 | ≈37.3 | 18.9 | अति मूल्यांकित | |
| मूल्य / FCF (TTM) | 15.55Y औसत ≈14.6 | ≈14.6 | · | · | |
| मूल्य / नकदी प्रवाह (TTM) | 8.45Y औसत ≈7.9 | ≈7.9 | 9.1 | अल्पमूल्यित | |
| EV / Revenue (EV / राजस्व) | 1.85Y औसत ≈1.8 | ≈1.8 | · | · | |
| EV / FCF | 17.75Y औसत ≈21.8 | ≈21.8 | · | · | |
| PEG Ratio (PEG अनुपात) | ≈0.7 | · | · | · |
सहकर्मी माध्यिका को प्रति मीट्रिक मानकीकृत आधार पर गणना की जाती है और यह हमेशा इस स्टॉक के लिए दिखाए गए TTM/MRQ आधार से मेल नहीं खा सकती है।
लाभप्रदता सकल, परिचालन और शुद्ध मार्जिन; ROE, ROA, ROIC
| मेट्रिक | 5Y रुझान | HCA | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| EBITDA Margin (EBITDA मार्जिन) | 4.7%5Y औसत ≈4.8% | ≈4.8% | 11.1% | कमजोर | |
| प्रीटैक्स मार्जिन (TTM) | 12.7%5Y औसत ≈13.6% | ≈13.6% | 10.3% | शीर्ष स्तर | |
| शुद्ध लाभ मार्जिन (TTM) | 8.8%5Y औसत ≈9.3% | ≈9.3% | 7.3% | अनुरूप | |
| ROA (TTM) | 11.1%5Y औसत ≈11.2% | ≈11.2% | 6.5% | शीर्ष स्तर | |
| ROE (TTM) | -124.0%5Y औसत ≈-963.7% | ≈-963.7% | 19.1% | कमजोर |
वित्तीय स्वास्थ्य ऋण, तरलता, शोधन क्षमता — बैलेंस शीट की मजबूती
| मेट्रिक | 5Y रुझान | HCA | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| ऋण / इक्विटी (MRQ) | -6.55Y औसत ≈-19.5 | ≈-19.5 | 0.1 | कम ऋण | |
| वर्तमान अनुपात (MRQ) | 1.05Y औसत ≈1.2 | ≈1.2 | 1.2 | कम तरलता | |
| Quick Ratio (त्वरित अनुपात) | 0.75Y औसत ≈0.9 | ≈0.9 | 0.9 | कम तरलता | |
| दीर्घकालिक ऋण / इक्विटी (MRQ) | -6.55Y औसत ≈-18.7 | ≈-18.7 | 0.1 | कम ऋण |
विकास राजस्व, EPS और शुद्ध आय वृद्धि: YoY, 3Y CAGR, 5Y CAGR
| मेट्रिक | 5Y रुझान | HCA | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Revenue YoY (राजस्व YoY) | 7.1%5Y औसत ≈8.0% | ≈8.0% | · | · | |
| Revenue CAGR 3Y (राजस्व CAGR 3Y) | 7.9%5Y औसत ≈7.4% | ≈7.4% | · | · | |
| Revenue CAGR 5Y (राजस्व CAGR 5Y) | 8.0% | · | · | · | |
| EPS YoY | 28.8%5Y औसत ≈25.6% | ≈25.6% | · | · | |
| Net Income YoY (शुद्ध आय YoY) | 17.8%5Y औसत ≈17.4% | ≈17.4% | · | · | |
| EPS CAGR 3Y | 13.9%5Y औसत ≈11.8% | ≈11.8% | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | |
| Net Income CAGR 3Y (शुद्ध आय CAGR 3Y) | 6.3%5Y औसत ≈4.0% | ≈4.0% | · | · | |
| Net Income CAGR 5Y (शुद्ध आय CAGR 5Y) | 12.6% | · | · | · |
पूंजी दक्षता एसेट टर्नओवर, इन्वेंटरी टर्नओवर, प्राप्य टर्नओवर
| मेट्रिक | 5Y रुझान | HCA | 5Y औसत | सहकर्मी माध्यिका | निर्णय |
|---|---|---|---|---|---|
| Asset Turnover (परिसंपत्ति टर्नओवर) | 1.35Y औसत ≈1.2 | ≈1.2 | 0.8 | शीर्ष स्तर | |
| Receivables Turnover (प्राप्य टर्नओवर) | 7.05Y औसत ≈7.1 | ≈7.1 | 8.3 | कमजोर | |
| Revenue / Employee (राजस्व / कर्मचारी (रिपोर्ट की गई हेडकाउंट, यफाइनांस)। व्युत्पन्न — संग्रहीत SEC-XBRL अवधारणा नहीं है।) | ≈$328.7K | · | · | · |
मान · ≈ 5Y औसत · उद्योग माध्य · माध्य के सापेक्ष निर्णय
लाभांश यील्ड, भुगतान अनुपात, लाभांश इतिहास, 5Y CAGR
| एक्स-डेट | राशि | मुद्रा | यील्ड |
|---|---|---|---|
| सित 16, 2026 | $0.78 | USD | ≈0.71% |
| जून 16, 2026 | $0.78 | USD | ≈0.76% |
| मा 17, 2026 | $0.78 | USD | ≈0.58% |
| दिस् 15, 2025 | $0.72 | USD | ≈0.60% |
| सित 16, 2025 | $0.72 | USD | ≈0.71% |
| जून 16, 2025 | $0.72 | USD | ≈0.75% |
| मा 17, 2025 | $0.72 | USD | ≈0.82% |
| दिस् 13, 2024 | $0.66 | USD | ≈0.84% |
| सित 16, 2024 | $0.66 | USD | ≈0.64% |
| जून 14, 2024 | $0.66 | USD | ≈0.75% |
| मा 14, 2024 | $0.66 | USD | ≈0.76% |
| दिस् 13, 2023 | $0.60 | USD | ≈0.89% |
| सित 14, 2023 | $0.60 | USD | ≈0.90% |
| जून 15, 2023 | $0.60 | USD | ≈0.81% |
| मा 16, 2023 | $0.60 | USD | ≈0.90% |
| दिस् 13, 2022 | $0.56 | USD | ≈0.92% |
| सित 15, 2022 | $0.56 | USD | ≈1.0% |
| जून 15, 2022 | $0.56 | USD | ≈1.1% |
| मा 16, 2022 | $0.56 | USD | ≈0.75% |
| दिस् 13, 2021 | $0.48 | USD | ≈0.90% |
Earnings History EPS वास्तविक बनाम अनुमान, आश्चर्य %, बीट दर, अगली आय तिथि
| Period | रिपोर्ट | EPS Actual | EPS अनुमान | आश्चर्य |
|---|---|---|---|---|
| 30 जून 2026 | जुल 23, 2026 | $7.62 | $7.54 | 1.0% |
| 31 मार्च 2026 | $7.15 | $7.21 | -0.85% | |
| 31 दिसमबर 2025 | $8.14 | $7.53 | 8.0% | |
| 30 सितमबर 2025 | $6.96 | $5.77 | 20.6% | |
| 30 जून 2025 | $6.83 | $6.31 | 8.2% | |
| 31 मार्च 2025 | $6.45 | $5.84 | 10.5% |
पूर्ण मौलिक सभी मेट्रिक्स प्रति वर्ष — आय विवरण, बैलेंस शीट, नकदी प्रवाह
आय विवरण
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| SG&A Expense | $548M | $421M | $353M | $307M | $337M | $416M | $370M | $344M | $340M | $343M | |
| Operating Expenses | $65.77B | $62.08B | $57.26B | $51.65B | $48.92B | $46.10B | $46.09B | $41.34B | $39.23B | $36.68B | |
| Interest Expense | $2.25B | $2.06B | $1.94B | $1.74B | $1.57B | $1.58B | $1.82B | $1.75B | $1.69B | $1.71B | |
| Pretax Income | $9.83B | $8.52B | $7.71B | $8.58B | $9.83B | $5.43B | $5.24B | $5.33B | $4.38B | $4.81B | |
| Income Tax | $2.05B | $1.87B | $1.61B | $1.75B | $2.11B | $1.04B | $1.10B | $946M | $1.64B | $1.38B | |
| Net Income | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| EPS (Basic) | $28.70 | $22.27 | $19.25 | $19.43 | $21.52 | $11.10 | $10.27 | $10.90 | $6.12 | $7.53 | |
| EPS (Diluted) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 | |
| Shares (Basic) | 236,413,000 | 258,603,000 | 272,404,000 | 290,348,000 | 323,315,000 | 338,274,000 | 341,210,000 | 347,297,000 | 362,305,000 | 383,591,000 | |
| Shares (Diluted) | 239,495,000 | 261,806,000 | 276,412,000 | 294,666,000 | 328,752,000 | 343,605,000 | 348,226,000 | 355,303,000 | 372,221,000 | 395,851,000 | |
| EBITDA | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B |
बैलेंस शीट
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.04B | $1.93B | $935M | $908M | $1.45B | $1.79B | $621M | $502M | $732M | $646M | |
| Short-term Investments | · | · | · | · | · | $116M | $147M | $47M | $54M | $49M | |
| Receivables | $10.87B | $10.75B | $9.96B | $8.89B | $8.10B | $7.05B | $7.38B | $6.79B | $6.50B | $5.83B | |
| Inventory | $1.65B | $1.74B | $2.02B | $2.07B | $1.99B | $2.02B | $1.85B | $1.73B | $1.57B | $1.50B | |
| Other Current Assets | $2.22B | $1.99B | $2.01B | $1.78B | $2.01B | $1.46B | $1.35B | $1.19B | $1.17B | $1.11B | |
| Current Assets | $15.78B | $16.41B | $14.93B | $13.64B | $13.54B | $12.33B | $11.20B | $10.21B | $9.98B | $9.09B | |
| PP&E (Net) | $31.14B | $29.41B | $27.71B | $25.57B | $24.06B | $23.20B | $22.71B | $19.76B | $17.89B | $16.35B | |
| PP&E (Gross) | $66.28B | $62.51B | $58.55B | $54.76B | $51.35B | $49.32B | $47.23B | $42.97B | $40.08B | $37.05B | |
| Accum. Depreciation | $35.13B | $33.10B | $30.83B | $29.18B | $27.29B | $26.12B | $24.52B | $23.21B | $22.19B | $20.70B | |
| Other Non-current Assets | $255M | $230M | $184M | $298M | $598M | $546M | $480M | $690M | $710M | $1.07B | |
| Total Assets | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Accounts Payable | $4.66B | $4.28B | $4.23B | $4.24B | $4.11B | $3.54B | $2.90B | $2.58B | $2.61B | $2.32B | |
| Current Liabilities | $16.35B | $15.18B | $12.65B | $9.90B | $9.58B | $8.70B | $7.76B | $7.57B | $6.16B | $5.83B | |
| Capital Leases | $1.85B | $1.86B | $1.90B | $1.75B | $1.75B | $1.67B | $1.50B | · | · | · | |
| Total Liabilities | · | · | · | · | · | · | $45.62B | $42.12B | $41.59B | $39.39B | |
| Long-term Debt | $44.28B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Total Debt | $41.60B | $43.03B | $39.59B | $38.08B | $34.58B | $31.00B | $33.72B | $32.82B | $33.06B | $31.38B | |
| Retained Earnings | $-5.72B | $-2.12B | $-1.35B | $-2.28B | $-532M | $777M | $-2.35B | $-4.57B | $-6.53B | $-6.97B | |
| AOCI | $-305M | $-387M | $-425M | $-490M | $-404M | $-502M | $-460M | $-381M | $-278M | $-338M | |
| Stockholders' Equity | $-6.03B | $-2.50B | $-1.77B | $-2.77B | $-933M | $572M | $-2.81B | $-4.95B | $-6.81B | $-7.30B | |
| Liabilities + Equity | $60.72B | $59.51B | $56.21B | $52.44B | $50.74B | $47.49B | $45.06B | $39.21B | $36.59B | $33.76B | |
| Shares Outstanding | 224,605,100 | 249,981,400 | 265,537,300 | 277,378,300 | 305,476,800 | 339,425,600 | 338,445,600 | 342,895,200 | 350,091,600 | 370,535,900 |
नकदी प्रवाह
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3.52B | $3.31B | $3.08B | $2.97B | $2.85B | $2.72B | $2.60B | $2.28B | $2.13B | $1.97B | |
| Stock-based Comp | $401M | $360M | $262M | $341M | $440M | $362M | $347M | $268M | $270M | $251M | |
| Amort. of Intangibles | $12M | $16M | $20M | $44M | $25M | $26M | · | · | · | · | |
| Other Non-cash | $1.93B | $1.08B | $850M | $-431M | $-1.29B | $2.40B | $1.07B | $461M | $-3.53B | $-2.67B | |
| Operating Cash Flow | $12.64B | $10.51B | $9.43B | $8.52B | $8.96B | $9.23B | $7.60B | $6.76B | $5.43B | $5.65B | |
| CapEx | $4.94B | $4.88B | $4.74B | $4.39B | $3.58B | $2.83B | $4.16B | $3.57B | $3.02B | $2.76B | |
| Investing Cash Flow | $-4.99B | $-4.93B | $-5.32B | $-3.39B | $-2.64B | $-3.39B | $-5.72B | $-3.90B | $-4.28B | $-3.24B | |
| Debt Issued | $8.47B | $7.50B | $3.22B | $6.00B | $4.34B | $2.70B | $6.45B | $2.00B | $1.50B | $5.40B | |
| Net Debt Issued | $1.08B | $5.08B | $2.31B | $3.17B | $475M | $-737M | $1.13B | $296M | $749M | $925M | |
| Stock Repurchased | $10.07B | $6.04B | $3.81B | $7.00B | $8.21B | $441M | $1.03B | $1.53B | $2.05B | $2.75B | |
| Net Stock Activity | $-10.07B | $-6.04B | $-3.81B | $-7.00B | $-8.21B | $-441M | $-1.03B | $-1.53B | $-2.05B | $-2.75B | |
| Dividends Paid | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · | |
| Financing Cash Flow | $-8.55B | $-4.58B | $-4.09B | $-5.66B | $-6.66B | $-4.68B | $-1.77B | $-3.08B | $-1.06B | $-2.51B | |
| Net Change in Cash | $-893M | $998M | $27M | $-543M | $-342M | $1.17B | $119M | $-230M | $86M | $-95M | |
| Taxes Paid | $1.74B | $1.84B | $1.39B | $1.18B | $2.18B | $1.00B | $849M | $872M | $1.21B | $1.25B | |
| Free Cash Flow | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | |
| Levered FCF | $5.91B | $4.03B | $3.16B | $2.74B | $4.15B | $5.12B | $2.00B | $1.74B | $1.35B | $1.68B |
लाभप्रदता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | 8.1% | · | · | |
| Pretax Margin | 13.0% | 12.1% | 11.9% | 14.2% | 16.7% | 10.5% | 10.2% | 11.4% | · | · | |
| EBITDA Margin | 4.7% | 4.7% | 4.7% | 4.9% | 4.9% | 5.3% | 5.1% | 4.9% | · | · | |
| ROA | 11.3% | 10.0% | 9.7% | 10.9% | 14.2% | 8.1% | 8.3% | 10.0% | 6.3% | 8.7% | |
| ROE | -159.1% | -269.6% | -230.9% | -305.0% | -3853.7% | -335.8% | -90.4% | -64.4% | -31.4% | -38.8% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.6 | 1.6 | |
| Quick Ratio | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 | 1.0 | 1.1 | 1.0 | 1.2 | 1.1 | |
| Debt / Equity | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 | 54.2 | -12.0 | -6.6 | -4.9 | -4.3 | |
| LT Debt / Equity | -6.9 | -15.3 | -21.0 | -13.6 | -36.8 | 53.8 | -12.0 | -6.5 | -4.8 | -4.3 |
दक्षता
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.2 | 1.2 | 1.2 | 1.2 | 1.1 | 1.2 | 1.2 | · | · | |
| Receivables Turnover | 7.0 | 6.8 | 6.9 | 7.1 | 7.8 | 7.1 | 7.2 | 7.0 | · | · |
प्रति शेयर
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-26.83 | $-10.00 | $-6.68 | $-9.98 | $-3.05 | $1.69 | $-8.30 | $-14.44 | $-19.44 | $-19.71 | |
| Revenue / Share | $315.66 | $269.68 | $235.04 | $204.41 | $178.71 | $149.98 | $147.42 | $131.37 | · | · | |
| Cash Flow / Share | $52.76 | $40.16 | $34.12 | $28.92 | $27.25 | $26.87 | $21.83 | $19.03 | $14.58 | $14.28 | |
| Cash / Share | $4.63 | $7.73 | $3.52 | $3.27 | $4.75 | $5.28 | $1.83 | $1.46 | $2.09 | $1.74 | |
| Dividend / Share | $2.88 | $2.64 | $2.40 | $2.24 | $1.92 | $0.43 | $1.60 | $1.40 | · | · | |
| EPS (TTM) | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 | $10.93 | $10.07 | $10.66 | $5.95 | $7.30 |
विकास दरें
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.1% | 8.7% | 7.9% | 2.5% | 14.0% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.9% | 6.3% | 8.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.0% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 28.8% | 16.0% | -0.94% | -9.5% | 93.6% | · | · | · | · | · | |
| EPS CAGR 3Y | 13.9% | 1.3% | 20.2% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 21.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 17.8% | 9.9% | -7.1% | -18.9% | 85.3% | · | · | · | · | · | |
| Net Income CAGR 3Y | 6.3% | -6.1% | 11.8% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 34.7% | · | · | · | · | · | · | · | · | · |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | $46.68B | $43.61B | $41.49B | |
| Net Income TTM | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | |
| Market Cap | $104.86B | $75.03B | $71.88B | $66.56B | $78.48B | $55.82B | $50.03B | $42.67B | $30.75B | $27.43B | |
| Enterprise Value | $145.42B | $116.13B | $110.53B | $103.74B | $111.61B | $84.92B | $82.98B | $74.95B | $63.02B | $58.11B | |
| P/E | 16.5 | 13.6 | 14.3 | 12.5 | 12.1 | 15.0 | 14.7 | 11.7 | 14.8 | 10.1 | |
| P/S | 1.4 | 1.1 | 1.1 | 1.1 | 1.3 | 1.1 | 1.0 | 0.9 | 0.7 | 0.7 | |
| P/B | -17.4 | -30.0 | -40.5 | -24.1 | -84.1 | 97.6 | -17.8 | -8.6 | -4.5 | -3.8 | |
| P / Tangible Book | · | · | · | · | · | 97.6 | · | · | · | · | |
| P / Cash Flow | 8.3 | 7.1 | 7.6 | 7.8 | 8.8 | 6.0 | 6.6 | 6.3 | 5.7 | 4.9 | |
| P / FCF | 13.6 | 13.3 | 15.3 | 16.1 | 14.6 | 8.7 | 14.5 | 13.4 | 12.8 | 9.5 | |
| EV / EBITDA | 41.3 | 35.1 | 35.9 | 34.9 | 39.1 | 31.2 | 32.0 | 32.9 | 29.6 | 29.6 | |
| EV / FCF | 18.9 | 20.6 | 23.6 | 25.1 | 20.7 | 13.3 | 24.1 | 23.5 | 26.1 | 20.1 | |
| EV / Revenue | 1.9 | 1.6 | 1.7 | 1.7 | 1.9 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | |
| Dividend Yield | 0.65% | 0.92% | 0.92% | 0.98% | 0.80% | 0.27% | 1.1% | 1.1% | 0.00% | · | |
| Earnings Yield | 6.1% | 7.3% | 7.0% | 8.0% | 8.2% | 6.7% | 6.8% | 8.6% | 6.8% | 9.9% | |
| Payout Ratio | 10.0% | 12.0% | 12.6% | 11.6% | 9.0% | 4.1% | 15.7% | 12.9% | · | · | |
| Annual Payout | $679M | $690M | $661M | $653M | $624M | $153M | $550M | $487M | $0 | · |
आय विवरण
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B | $18.32B | $18.29B | $17.49B | $17.49B | $17.34B | $17.30B | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | |
| SG&A Expense | $148M | $133M | $153M | $139M | $130M | $126M | $120M | $111M | $100M | $90M | $108M | $89M | $82M | $74M | $79M | $74M | |
| Operating Expenses | $17.74B | $16.82B | $16.84B | $16.74B | $16.19B | $15.99B | $16.15B | $15.58B | $15.26B | $15.09B | $14.96B | $14.58B | $14.05B | $13.67B | $12.20B | $13.27B | |
| Interest Expense | $599M | $584M | $572M | $561M | $568M | $547M | $528M | $515M | $506M | $512M | $491M | $483M | $485M | $479M | $453M | $446M | |
| Pretax Income | $2.49B | $2.29B | $2.67B | $2.42B | $2.42B | $2.33B | $2.13B | $1.91B | $2.24B | $2.25B | $2.35B | $1.63B | $1.81B | $1.92B | $3.30B | $1.70B | |
| Income Tax | $564M | $430M | $509M | $515M | $524M | $502M | $447M | $424M | $550M | $445M | $484M | $355M | $397M | $379M | $656M | $360M | |
| Net Income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B | $1.61B | $1.44B | $1.27B | $1.46B | $1.59B | $1.61B | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | |
| EPS (Basic) | $7.70 | $7.25 | $8.22 | $7.05 | $6.91 | $6.52 | $5.72 | $4.94 | $5.60 | $6.01 | $6.00 | $3.98 | $4.35 | $4.92 | $7.30 | $3.97 | |
| EPS (Diluted) | $7.62 | $7.15 | $8.09 | $6.96 | $6.83 | $6.45 | $5.66 | $4.88 | $5.53 | $5.93 | $5.92 | $3.91 | $4.29 | $4.85 | $7.20 | $3.91 | |
| Shares (Basic) | 220,538,000 | 223,588,000 | · | 232,891,000 | 239,173,000 | 246,936,000 | · | 256,763,000 | 261,156,000 | 264,435,000 | · | 271,173,000 | 274,494,000 | 276,910,000 | · | 285,958,000 | |
| Shares (Diluted) | 222,828,000 | 226,652,000 | · | 236,181,000 | 241,911,000 | 249,440,000 | · | 259,917,000 | 264,071,000 | 268,016,000 | · | 275,424,000 | 278,198,000 | 280,961,000 | · | 289,852,000 | |
| EBITDA | $944M | $930M | · | $889M | $863M | $860M | · | $842M | $819M | $795M | · | $769M | $763M | $756M | · | $749M |
बैलेंस शीट
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $940M | $1.04B | $997M | $939M | $1.06B | $1.93B | $2.89B | $831M | $1.28B | · | $891M | $862M | $842M | · | $999M | |
| Receivables | $12.28B | $11.32B | $10.87B | $10.43B | $10.46B | $11.09B | $10.75B | $9.91B | $10.24B | $10.04B | · | $9.18B | $8.71B | $8.66B | · | $8.55B | |
| Inventory | $1.66B | $1.68B | $1.65B | $1.73B | $1.79B | $1.79B | $1.74B | $1.78B | $1.80B | $1.90B | · | $2.03B | $2.05B | $2.08B | · | $2.01B | |
| Other Current Assets | $2.23B | $2.11B | $2.22B | $2.13B | $2.37B | $2.32B | $1.99B | $2.08B | $2.30B | $2.05B | · | $2.19B | $2.26B | $1.96B | · | $1.92B | |
| Current Assets | $17.19B | $16.05B | $15.78B | $15.29B | $15.56B | $16.26B | $16.41B | $16.66B | $15.17B | $15.28B | · | $14.29B | $13.89B | $13.54B | · | $13.48B | |
| PP&E (Net) | $31.82B | $31.47B | $31.14B | $30.57B | $30.12B | $29.74B | $29.41B | $29.05B | $28.64B | $28.10B | · | $27.12B | $26.64B | $26.05B | · | $24.98B | |
| PP&E (Gross) | $68.41B | $67.36B | $66.28B | $65.49B | $64.39B | $63.68B | $62.51B | $61.75B | $60.62B | $59.44B | · | $57.77B | $56.67B | $55.46B | · | $53.73B | |
| Accum. Depreciation | $36.59B | $35.89B | $35.13B | $34.92B | $34.27B | $33.94B | $33.10B | $32.70B | $31.99B | $31.34B | · | $30.66B | $30.02B | $29.41B | · | $28.75B | |
| Other Non-current Assets | $258M | $326M | $255M | $277M | $236M | $226M | $230M | $309M | $240M | $199M | · | $200M | $196M | $319M | · | $461M | |
| Total Assets | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | $56.21B | $54.59B | $53.59B | $52.71B | $52.44B | $51.48B | |
| Accounts Payable | $4.75B | $4.81B | $4.66B | $4.55B | $4.25B | $4.49B | $4.28B | $4.24B | $4.03B | $4.74B | · | $4.14B | $3.82B | $3.77B | · | $4.16B | |
| Current Liabilities | $17.31B | $19.26B | $16.35B | $17.90B | $15.94B | $13.63B | $15.18B | $14.90B | $14.30B | $13.14B | · | $12.41B | $11.54B | $11.03B | · | $9.78B | |
| Capital Leases | $1.83B | $1.82B | $1.85B | $1.84B | $1.88B | $1.86B | $1.86B | $1.92B | $1.89B | $1.91B | · | $1.78B | $1.81B | $1.72B | · | $1.76B | |
| Long-term Debt | $45.83B | $44.37B | $44.28B | $42.60B | $42.70B | $44.58B | $43.03B | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Total Debt | $43.45B | $39.49B | · | $38.40B | $39.38B | $44.58B | · | $42.97B | $40.88B | $40.19B | · | $39.35B | $38.93B | $38.86B | · | $37.71B | |
| Retained Earnings | $-6.31B | $-5.98B | $-5.72B | $-5.02B | $-4.09B | $-3.16B | $-2.12B | $-1.81B | $-1.17B | $-1.19B | · | $-1.99B | $-1.85B | $-2.03B | · | $-2.78B | |
| AOCI | $-334M | $-327M | $-305M | $-317M | $-309M | $-357M | $-387M | $-378M | $-433M | $-433M | $-425M | $-491M | $-456M | $-470M | $-490M | $-592M | |
| Stockholders' Equity | $-6.64B | $-6.30B | $-6.03B | $-5.33B | $-4.39B | $-3.52B | $-2.50B | $-2.18B | $-1.60B | $-1.61B | · | $-2.48B | $-2.30B | $-2.50B | · | $-3.37B | |
| Liabilities + Equity | $63.25B | $61.45B | $60.72B | $59.75B | $59.54B | $59.80B | $59.51B | $59.46B | $57.38B | $56.96B | · | $54.59B | $53.59B | $52.71B | · | $51.48B | |
| Shares Outstanding | 217,963,300 | 222,530,900 | 224,605,100 | 229,845,100 | 236,143,900 | 242,955,400 | 249,981,400 | 254,517,700 | 259,237,600 | 263,215,800 | · | 268,967,300 | 272,931,700 | 275,939,900 | · | 283,903,500 |
नकदी प्रवाह
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $944M | $930M | $911M | $889M | $863M | $860M | $856M | $842M | $819M | $795M | $789M | $769M | $763M | $756M | $750M | $749M | |
| Stock-based Comp | $85M | $86M | $100M | $104M | $99M | $98M | $85M | $76M | $112M | $87M | $57M | $72M | $56M | $77M | $83M | $87M | |
| Other Non-cash | · | $-622M | · | · | · | $-917M | · | · | · | $-4M | · | · | · | $-393M | · | · | |
| Operating Cash Flow | $2.33B | $2.01B | $2.36B | $4.42B | $4.21B | $1.65B | $2.56B | $3.52B | $1.97B | $2.47B | $2.67B | $2.48B | $2.48B | $1.80B | $2.53B | $3.02B | |
| CapEx | $1.23B | $1.12B | $1.49B | $1.29B | $1.18B | $991M | $1.28B | $1.19B | $1.28B | $1.12B | $1.16B | $1.15B | $1.24B | $1.20B | $1.32B | $1.13B | |
| Investing Cash Flow | $-1.56B | $-1.28B | $-1.32B | $-1.39B | $-1.25B | $-1.03B | $-1.35B | $-1.35B | $-1.33B | $-903M | $-1.60B | $-1.31B | $-1.26B | $-1.15B | $-793M | $-546M | |
| Debt Issued | $2.99B | $0 | $3.24B | $0 | $0 | $5.23B | $0 | $3.01B | $0 | $4.48B | $4M | $2M | $3.22B | $0 | $21M | $10M | |
| Net Debt Issued | · | $-58M | · | · | · | $1.34B | · | · | · | $2.42B | · | · | · | $-550M | · | · | |
| Stock Repurchased | $2.06B | $1.57B | $2.56B | $2.50B | $2.50B | $2.51B | $1.70B | $1.79B | $1.37B | $1.18B | $910M | $1.14B | $915M | $846M | $1.52B | $698M | |
| Net Stock Activity | · | $-1.57B | · | · | · | $-2.51B | · | · | · | $-1.18B | · | · | · | $-846M | · | · | |
| Dividends Paid | $171M | $183M | $162M | $166M | $171M | $180M | $165M | $169M | $171M | $185M | $160M | $162M | $164M | $175M | $156M | $160M | |
| Financing Cash Flow | $-704M | $-830M | $-999M | $-2.97B | $-3.09B | $-1.50B | $-2.16B | $-110M | $-1.09B | $-1.22B | $-1.04B | $-1.13B | $-1.20B | $-725M | $-1.84B | $-2.32B | |
| Net Change in Cash | $73M | $-100M | $43M | $58M | $-121M | $-873M | $-955M | $2.06B | $-453M | $349M | $44M | $29M | $20M | $-66M | $-91M | $141M | |
| Taxes Paid | $730M | $-5M | $1.51B | $81M | $136M | $10M | $358M | $487M | $998M | $1M | $316M | $297M | $766M | $7M | $244M | $322M | |
| Free Cash Flow | · | $895M | · | · | · | $660M | · | · | · | $1.35B | · | · | · | $606M | · | · | |
| Levered FCF | · | $421M | · | · | · | $231M | · | · | · | $940M | · | · | · | $221M | · | · |
लाभप्रदता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 8.4% | 8.5% | · | 8.6% | 8.9% | 8.8% | · | 7.3% | 8.3% | 9.2% | · | 6.7% | 7.5% | 8.7% | · | 7.6% | |
| Pretax Margin | 12.3% | 12.0% | · | 12.6% | 13.0% | 12.7% | · | 10.9% | 12.8% | 13.0% | · | 10.1% | 11.4% | 12.3% | · | 11.4% | |
| EBITDA Margin | 4.7% | 4.9% | · | 4.6% | 4.6% | 4.7% | · | 4.8% | 4.7% | 4.6% | · | 4.7% | 4.8% | 4.9% | · | 5.0% | |
| ROA | 2.8% | 2.7% | · | 2.8% | 2.8% | 2.8% | · | 2.2% | 2.6% | 2.9% | · | 2.0% | 2.3% | 2.6% | · | 2.2% | |
| ROE | -30.8% | -33.0% | · | -43.7% | -55.2% | -62.7% | · | -54.5% | -74.9% | -77.4% | · | -36.9% | -39.9% | -60.2% | · | -55.8% |
तरलता और शोधन क्षमता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 0.9 | 1.0 | 1.2 | · | 1.1 | 1.1 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | |
| Quick Ratio | 0.8 | 0.6 | · | 0.6 | 0.7 | 0.9 | · | 0.9 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | 1.0 | |
| Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -12.7 | · | -19.7 | -25.6 | -24.9 | · | -15.9 | -16.9 | -15.6 | · | -11.2 | |
| LT Debt / Equity | -6.5 | -6.3 | · | -7.2 | -9.0 | -11.7 | · | -17.5 | -22.7 | -23.0 | · | -14.9 | -15.9 | -14.6 | · | -11.1 |
दक्षता
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 1.8 | 1.7 | · | 1.9 | 1.8 | 1.7 | · | 1.8 | 1.8 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 1.8 |
प्रति शेयर
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-30.47 | $-28.32 | · | $-23.21 | $-18.61 | $-14.48 | · | $-8.57 | $-6.17 | $-6.14 | · | $-9.21 | $-8.44 | $-9.04 | · | $-11.87 | |
| Revenue / Share | $90.79 | $84.31 | · | $81.13 | $76.91 | $73.45 | · | $67.28 | $66.24 | $64.69 | · | $58.87 | $57.01 | $55.49 | · | $51.65 | |
| Cash Flow / Share | · | $8.89 | · | · | · | $6.62 | · | · | · | $9.21 | · | · | · | $6.42 | · | · | |
| Cash / Share | $4.65 | $4.22 | · | $4.34 | $3.98 | $4.36 | · | $11.35 | $3.21 | $4.88 | · | $3.31 | $3.16 | $3.05 | · | $3.52 | |
| Dividend / Share | $0.78 | $0.78 | $0.72 | $0.72 | $0.72 | $0.72 | $0.66 | $0.66 | $0.66 | $0.66 | $0.60 | $0.60 | $0.60 | $0.60 | $0.56 | $0.56 | |
| EPS (TTM) | $29.82 | $29.03 | · | $25.90 | $23.82 | $22.52 | · | $22.26 | $21.29 | $20.05 | · | $20.25 | $20.25 | $19.86 | · | $17.61 |
मूल्यांकन (TTM)
| मेट्रिक | रुझान | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $78.01B | $76.39B | · | $74.37B | $72.70B | $71.58B | · | $69.62B | $68.35B | $66.72B | · | $63.16B | $61.92B | $60.88B | · | $59.80B | |
| Net Income TTM | $6.84B | $6.79B | · | $6.34B | $5.97B | $5.78B | · | $5.93B | $5.74B | $5.47B | · | $5.72B | $5.77B | $5.73B | · | $5.38B | |
| Market Cap | $84.98B | $105.31B | · | $97.96B | $90.47B | $83.95B | · | $103.44B | $83.29B | $87.79B | · | $66.16B | $82.83B | $72.76B | · | $52.18B | |
| Enterprise Value | $127.42B | $143.86B | · | $135.36B | $128.91B | $127.47B | · | $143.52B | $123.34B | $126.70B | · | $104.62B | $120.90B | $110.77B | · | $88.89B | |
| P/E | 13.1 | 16.3 | · | 16.5 | 16.1 | 15.3 | · | 18.3 | 15.1 | 16.6 | · | 12.1 | 15.0 | 13.3 | · | 10.4 | |
| P/S | 1.1 | 1.4 | · | 1.3 | 1.2 | 1.2 | · | 1.5 | 1.2 | 1.3 | · | 1.0 | 1.3 | 1.2 | · | 0.9 | |
| P/B | -12.8 | -16.7 | · | -18.4 | -20.6 | -23.9 | · | -47.4 | -52.1 | -54.4 | · | -26.7 | -36.0 | -29.2 | · | -15.5 | |
| P / Cash Flow | · | 52.3 | · | · | · | 50.8 | · | · | · | 35.6 | · | · | · | 40.4 | · | · | |
| EV / Revenue | 1.6 | 1.9 | · | 1.8 | 1.8 | 1.8 | · | 2.1 | 1.8 | 1.9 | · | 1.7 | 2.0 | 1.8 | · | 1.5 | |
| Dividend Yield | 0.80% | 0.65% | · | 0.70% | 0.76% | 0.82% | · | 0.66% | 0.81% | 0.76% | · | 0.99% | 0.79% | 0.89% | · | 1.2% | |
| Earnings Yield | 7.6% | 6.1% | · | 6.1% | 6.2% | 6.5% | · | 5.5% | 6.6% | 6.0% | · | 8.2% | 6.7% | 7.5% | · | 9.6% | |
| Payout Ratio | · | 11.3% | · | · | · | 11.2% | · | · | · | 11.6% | · | · | · | 12.8% | · | · | |
| Annual Payout | $682M | $682M | · | $682M | $685M | $685M | · | $685M | $678M | $671M | · | $657M | $655M | $651M | · | $645M |
सबसे हाल की अवधि बाईं ओर · शून्य मान इस प्रकार दिखाए गए हैं ·
वित्तीय विवरण आय विवरण, बैलेंस शीट, नकदी प्रवाह — वार्षिक, पिछले 5 वर्ष
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| राजस्व | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B |
| शुद्ध आय | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B |
| तनुकरणित EPS | $28.33 | $22.00 | $18.97 | $19.15 | $21.16 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| ऋण / इक्विटी | -6.9 | -17.2 | -22.3 | -13.8 | -37.1 |
| वर्तमान अनुपात | 1.0 | 1.1 | 1.2 | 1.4 | 1.4 |
| त्वरित अनुपात | 0.7 | 0.8 | 0.9 | 1.0 | 1.0 |
| मेट्रिक | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| फ्री कैश फ्लो | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B |
संस्थागत मालिक (13F) 1473 फाइलर्स · $57.3B कुल · तिथि अनुसार 30 सितमबर 2026
संस्थान जो अपनी तिमाही SEC फॉर्म 13F में इस स्टॉक को होल्ड करने की रिपोर्ट करते हैं। केवल लॉन्ग पोजीशन; एक ही फाइलर अलग-अलग ऑप्शन लेग्स के लिए दो बार दिखाई दे सकता है। बड़े ऑफसेटिंग पुट/कॉल लेग्स आमतौर पर मार्केट-मेकिंग या हेज्ड इन्वेंट्री को दर्शाते हैं, न कि दिशात्मक विश्वास को।
| नई स्थितियाँ | बाहर निकली पोजीशन | बढ़ाया | घटा हुआ | शुद्ध शेयर परिवर्तन |
|---|---|---|---|---|
| 121 (-64 पिछली तिमाही की तुलना में) | 176 (+72 पिछली तिमाही की तुलना में) | 458 (-25 पिछली तिमाही की तुलना में) | 581 (+4 पिछली तिमाही की तुलना में) | -627K |
Q1 2026 की तुलना में। SEC फॉर्म 13F फाइलिंग तिमाही के अंत के 45 दिनों के भीतर देय होती है, साथ ही देर से फाइल करने वालों के लिए एक छोटा बफर भी होता है — उस विंडो के भीतर आने वाली तिमाहियों को सबसे हालिया पूरी तरह से रिपोर्ट की गई जोड़ी के पक्ष में छोड़ दिया जाता है।
| संस्था | मूल्य | शेयर | % ट्रैक किए गए 13F का | प्रकार |
|---|---|---|---|---|
| VANGUARD GROUP INC | $6870392526 | 14716173 | 12.00% | शेयर |
| BlackRock, Inc. | $5069973824 | 13003600 | 8.85% | शेयर |
| VANGUARD CAPITAL MANAGEMENT LLC | $3954150533 | 10141708 | 6.91% | शेयर |
| Sanders Capital, LLC | $3442060818 | 8828287 | 6.01% | शेयर |
| STATE STREET CORP | $2912102056 | 7469035 | 5.09% | शेयर |
| WELLINGTON MANAGEMENT GROUP LLP | $1835396649 | 4707473 | 3.21% | शेयर |
| GEODE CAPITAL MANAGEMENT, LLC | $1423654808 | 3668008 | 2.49% | शेयर |
| First Eagle Investment Management, LLC | $1284907912 | 3295565 | 2.24% | शेयर |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1057704509 | 2712828 | 1.85% | शेयर |
| MORGAN STANLEY | $1008556857 | 2586771 | 1.76% | शेयर |
| GOLDMAN SACHS GROUP INC | $960811481 | 2464314 | 1.68% | शेयर |
| JPMORGAN CHASE & CO | $896800955 | 2285832 | 1.57% | शेयर |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $861456107 | 2209485 | 1.50% | शेयर |
| NORGES BANK | $836457140 | 2145367 | 1.46% | शेयर |
| Capital World Investors | $770864224 | 1977121 | 1.35% | शेयर |
| Capital International Investors | $747403041 | 1916947 | 1.31% | शेयर |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $709859997 | 1500000 | 1.24% | शेयर |
| NORTHERN TRUST CORP | $666150458 | 1708560 | 1.16% | शेयर |
| FMR LLC | $636503475 | 1632520 | 1.11% | शेयर |
| Invesco Ltd. | $596390232 | 1529637 | 1.04% | शेयर |
| NORDEA INVESTMENT MANAGEMENT AB | $553702529 | 1429943 | 0.97% | शेयर |
| BARCLAYS PLC | $514349127 | 1319216 | 0.90% | शेयर |
| JANUS HENDERSON GROUP PLC | $481486890 | 1017441 | 0.84% | शेयर |
| Crake Asset Management LLP | $449072183 | 1151792 | 0.78% | शेयर |
| Metropolis Capital Ltd | $430915307 | 910564 | 0.75% | शेयर |
| Darsana Capital Partners LP | $428879000 | 1100000 | 0.75% | शेयर |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $414565358 | 1063288 | 0.72% | शेयर |
| Legal & General Group Plc | $410992402 | 1054124 | 0.72% | शेयर |
| FRANKLIN RESOURCES INC | $399958688 | 1025824 | 0.70% | शेयर |
| Life Cycle Investment Partners Ltd | $355737196 | 912404 | 0.62% | शेयर |
| Bank of New York Mellon Corp | $350359895 | 898612 | 0.61% | शेयर |
| VANGUARD FIDUCIARY TRUST CO | $339685814 | 871235 | 0.59% | शेयर |
| ROYAL BANK OF CANADA | $320194000 | 821241 | 0.56% | शेयर |
| LYRICAL ASSET MANAGEMENT LP | $255015742 | 654071 | 0.45% | शेयर |
| BANK OF AMERICA CORP /DE/ | $238456934 | 611601 | 0.42% | शेयर |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $237236367 | 608470 | 0.41% | शेयर |
| ROYAL LONDON ASSET MANAGEMENT LTD | $235649908 | 604401 | 0.41% | शेयर |
| PRINCIPAL FINANCIAL GROUP INC | $234827401 | 602290 | 0.41% | शेयर |
| UBS Group AG | $230953291 | 592355 | 0.40% | शेयर |
| National Pension Service | $230650346 | 591578 | 0.40% | शेयर |
| Russell Investments Group, Ltd. | $206832565 | 530340 | 0.36% | शेयर |
| Nuveen, LLC | $199595109 | 511927 | 0.35% | शेयर |
| Gobi Capital LLC | $195742325 | 502045 | 0.34% | शेयर |
| Cryder Capital Partners LLP | $194561738 | 499017 | 0.34% | शेयर |
| Allianz Asset Management GmbH | $181127299 | 464560 | 0.32% | शेयर |
| DEUTSCHE BANK AG\ | $175985429 | 451372 | 0.31% | शेयर |
| Swiss National Bank | $172097446 | 441400 | 0.30% | शेयर |
| DIMENSIONAL FUND ADVISORS LP | $172079393 | 441313 | 0.30% | शेयर |
| AustralianSuper Pty Ltd | $159635782 | 409438 | 0.28% | शेयर |
| HSBC HOLDINGS PLC | $158555065 | 406750 | 0.28% | शेयर |
कार्यकर्ता और 5%+ मालिक 4 होल्डिंग्स
जिन निवेशकों ने SEC शेड्यूल 13D दाखिल किया है — जारीकर्ता को प्रभावित करने के इरादे से 5% से अधिक लाभकारी स्वामित्व (कार्यकर्ता दांव, बोर्ड अभियान, M&A)। प्रत्येक पंक्ति उस फाइलर की स्थिति की सबसे हालिया ज्ञात स्थिति दिखाती है।
| फाइलर | दाखिल किया | दांव | स्थिति | उद्देश्य | फाइलिंग |
|---|---|---|---|---|---|
| Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan | 10 फ़रवरी 2026 | 31.60% | प्रारंभिक फाइलिंग | · | SEC |
| 22 नवमबर 2006 | · | प्रारंभिक फाइलिंग | · | SEC | |
| Merrill Lynch Bank USA | 11 सितमबर 2006 | · | प्रारंभिक फाइलिंग | · | SEC |
| Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC | 4 अगस्त 2006 | · | प्रारंभिक फाइलिंग | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
कंपनी के अंदरूनी सूत्र 92 इनसाइडर्स · 54 अधिकारी · 31 निदेशक
| अंदरूनी | भूमिका | अंतिम गतिविधि | शेयरों का स्वामित्व | खरीद 12m | बिक्री 12m | नेट 12m |
|---|---|---|---|---|---|---|
| Samuel N Hazen | CEO | 10 फ़रवरी 2026 F | 64842 | 0 | 7 | $-21483290 |
| O'Boyle Michael P | President & CEO - Parallon | 26 फ़रवरी 2013 A | 21429 | 0 | 0 | $0 |
| Mike A Marks | EVP and CFO | 7 मई 2026 G | 46576 | 0 | 0 | $0 |
| Bill B Rutherford | CFO and EVP | 16 फ़रवरी 2024 F | 22251 | 0 | 0 | $0 |
| Russell K Harms | CFO - Central Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Robert Samuel Hankins JR | CFO-Outpatient Services Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Richard J Shallcross | CFO - Western Group | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Jeffrey T Crudele | CFO-Eastern Division | 1 जुलाई 2005 F | 13865 | 0 | 0 | $0 |
| Erol R Akdamar | Group President | 12 नवमबर 2024 M | 6843 | 0 | 0 | $0 |
| Timothy M Mcmanus | Group President | 31 जुलाई 2024 M | 27008 | 0 | 0 | $0 |
| Richard A Hammett | Group President | 16 फ़रवरी 2024 F | 17936 | 0 | 0 | $0 |
| Charles J Hall | Group President | 11 नवमबर 2022 M | 202443 | 0 | 0 | $0 |
| Bruce A Moore JR | Group President - Service Line | 11 नवमबर 2022 S | 30807 | 0 | 0 | $0 |
| Paul W Rutledge | Group President | 31 दिसमबर 2012 A | 335657 | 0 | 0 | $0 |
| Beverly B Wallace | President - Parallon | 2 नवमबर 2011 M | 144714 | 0 | 0 | $0 |
| Charles Robert Evans | President - Eastern Group | 26 जुलाई 2006 A | 62173 | 0 | 0 | $0 |
| Marilyn B Tavenner | President-Outpatient Svcs Grp | 27 अक्टूबर 2005 A | 26154 | 0 | 0 | $0 |
| Greg Roth | President-Ambulatory Surgery | 31 अक्टूबर 2004 D | 9029 | 0 | 0 | $0 |
| Jay Grinney | President-Eastern Group | 7 मई 2004 D | 24177 | 0 | 0 | $0 |
| Jon M Foster | EVP and COO | 10 फ़रवरी 2026 F | 23062 | 0 | 0 | $0 |
| Michael R Mcalevey | EVP & Chief Legal & Admin Off. | 26 अगस्त 2026 J | 0 | 0 | 2 | $-2747520 |
| Jennifer Berres | SVP & Chief Human Res. Officer | 11 फ़रवरी 2026 S | 11993 | 0 | 2 | $-4126932 |
| Christopher F. Wyatt | SVP & Controller | 11 फ़रवरी 2026 S | 44379 | 0 | 1 | $-2020000 |
| Erica Rossitto | SVP & Chief Nurse Executive | 10 फ़रवरी 2026 F | 10407 | 0 | 0 | $0 |
| Michael S. Cuffe | EVP and Chief Clinical Officer | 10 फ़रवरी 2026 F | 32080 | 0 | 1 | $-747135 |
| Sammie S Mosier | SVP & Chief Nurse Executive | 13 फ़रवरी 2025 F | 11113 | 0 | 0 | $0 |
| Kathleen M Whalen | SVP & Chief Ethics Officer | 14 नवमबर 2024 S | 9454 | 0 | 0 | $0 |
| Phillip G Billington | SVP-Internal Audit Services | 12 नवमबर 2024 M | 52702 | 0 | 0 | $0 |
| Joseph A Sowell III | SVP; Chief Development Officer | 5 अगस्त 2024 G | 18526 | 0 | 0 | $0 |
| Deborah M Reiner | SVP - Mktg. & Communications | 29 जुलाई 2024 S | 3510 | 0 | 0 | $0 |
| Kathryn A. Torres | SVP-Payer Contracting & Align. | 25 जुलाई 2024 S | 17755 | 0 | 0 | $0 |
| Jeffrey E. Cohen | SVP-Government Relations | 9 मई 2024 S | 5185 | 0 | 0 | $0 |
| Chad J Wasserman | SVP and CIO | 18 मार्च 2024 M | 1576 | 0 | 0 | $0 |
| Martin P. Paslick | SVP and CIO | 12 अप्रैल 2023 M | 24643 | 0 | 0 | $0 |
| Jane D. Englebright | SVP and Chief Nursing Officer | 9 नवमबर 2021 S | 0 | 0 | 0 | $0 |
| Robert A Waterman | SVP & General Counsel | 5 मई 2021 S | 50062 | 0 | 0 | $0 |
| William J Morrow | SVP - Finance and Treasurer | 18 फ़रवरी 2021 F | 5578 | 0 | 0 | $0 |
| Sandra L. Morgan | SVP-Provider Relations | 18 फ़रवरी 2021 F | 10122 | 0 | 0 | $0 |
| Victor L Campbell | SVP-Government Affairs | 1 मई 2019 A | 194145 | 0 | 0 | $0 |
| John M Steele | SVP & Chief Human Res. Officer | 25 फ़रवरी 2019 M | 84157 | 0 | 0 | $0 |
| Milton R Johnson | Chairman | 25 फ़रवरी 2019 M | 881823 | 0 | 0 | $0 |
| Ravi S. Chari | SVP-Clinical Excellence | 25 फ़रवरी 2018 M | 7003 | 0 | 0 | $0 |
| Alan R Yuspeh | SVP & Chief Ethics Officer | 25 फ़रवरी 2018 M | 35546 | 0 | 0 | $0 |
| Joseph N Steakley | SVP-Internal Audit Services | 25 फ़रवरी 2018 M | 65199 | 0 | 0 | $0 |
| Jana Joustra Davis | SVP - Mktg. & Corp. Affairs | 23 मई 2017 M | 26378 | 0 | 0 | $0 |
| David Gwin Anderson | SVP - Finance | 7 नवमबर 2016 M | 110167 | 0 | 0 | $0 |
| Donald W Stinnett | SVP & Controller | 25 फ़रवरी 2016 A | 51965 | 0 | 0 | $0 |
| Noel B Williams | SVP and CIO | 16 मई 2012 M | 299030 | 0 | 0 | $0 |
| Jack O Bovender JR | Chairman | 6 अक्टूबर 2009 A | 188340 | 0 | 0 | $0 |
| Carl V George | SVP - Development | 27 फ़रवरी 2009 M | 13092 | 0 | 0 | $0 |
| Patricia T Lindler | SVP - Government Programs | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Rosalyn S Elton | SVP-Operations Finance | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Frank M Houser MD | SVP-Quality & Medical Director | 26 जुलाई 2006 A | 46145 | 0 | 0 | $0 |
| James A Fitzgerald JR | SVP-Supply Chain Operations | 29 जनवरी 2006 F | 20674 | 0 | 0 | $0 |
| Andrea B Smith | निदेशक | 28 अप्रैल 2026 A | 4666 | 0 | 0 | $0 |
| William R Frist | निदेशक | 28 अप्रैल 2026 A | 13740 | 0 | 0 | $0 |
| Wayne Joseph Riley | निदेशक | 28 अप्रैल 2026 A | 15029 | 0 | 0 | $0 |
| Hugh F Johnston | निदेशक | 28 अप्रैल 2026 A | 4475 | 0 | 0 | $0 |
| Thomas F Frist III | निदेशक | 28 अप्रैल 2026 A | 15858 | 0 | 0 | $0 |
| Michael W Michelson | निदेशक | 28 अप्रैल 2026 A | 12576 | 0 | 0 | $0 |
| Nancy Ann Deparle | निदेशक | 28 अप्रैल 2026 A | 21910 | 0 | 0 | $0 |
| John Chidsey | निदेशक | 28 अप्रैल 2026 A | 1305 | 0 | 0 | $0 |
| Robert J Dennis | निदेशक | 29 अप्रैल 2025 A | 26601 | 0 | 0 | $0 |
| Meg Crofton | निदेशक | 29 अप्रैल 2024 A | 6331 | 0 | 0 | $0 |
| Charles O Holliday JR | निदेशक | 25 अप्रैल 2022 A | 18955 | 0 | 0 | $0 |
| Geoffrey G Meyers | निदेशक | 1 मई 2019 A | 39153 | 0 | 0 | $0 |
| John W Rowe | निदेशक | 1 मई 2019 A | 30388 | 0 | 0 | $0 |
| Ann H Lamont | निदेशक | 2 मई 2018 A | 17661 | 0 | 0 | $0 |
| Jay O Light | निदेशक | 3 मई 2017 A | 30953 | 0 | 0 | $0 |
| Stephen G Pagliuca | निदेशक | 5 दिसमबर 2014 D | 7612921 | 0 | 0 | $0 |
| Christopher R Gordon | निदेशक | 1 नवमबर 2013 D | 30003156 | 0 | 0 | $0 |
| John Connaughton | निदेशक | 1 नवमबर 2013 D | 30003156 | 0 | 0 | $0 |
| John H Mcarthur | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Kent C Nelson | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Magdalena Averhoff MD | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Glenda A Hatchett | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Frederick W Gluck | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Harold T Shapiro | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Michael C Armstrong | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Martin Feldstein | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Michael T Long | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| ROYAL FRANK S | निदेशक | 17 नवमबर 2006 D | 0 | 0 | 0 | $0 |
| Patricia F Elcan | 10% मालिक | 6 फ़रवरी 2026 J | 36557141 | 0 | 0 | $0 |
| Frisco Holding II | 10% मालिक | 6 फ़रवरी 2026 J | 36557141 | 0 | 0 | $0 |
| HERCULES HOLDING II, LLC | 10% मालिक | 6 फ़रवरी 2026 J | 32282889 | 0 | 0 | $0 |
| Thomas F Frist JR | 10% मालिक | 6 फ़रवरी 2026 J | 36557141 | 0 | 0 | $0 |
| Patricia C Frist | 10% मालिक | 20 फ़रवरी 2018 G | 0 | 0 | 0 | $0 |
| KKR PEI GP LTD | 10% मालिक | 1 अप्रैल 2014 J | 0 | 0 | 0 | $0 |
| Jonathan B Perlin | · | 2 अगस्त 2021 S | 44348 | 0 | 0 | $0 |
| Juan Vallarino | · | 9 मई 2016 M | 61036 | 0 | 0 | $0 |
| Richard M Bracken | · | 31 दिसमबर 2014 F | 82499 | 0 | 0 | $0 |
| BANK OF AMERICA CORP /DE/ | · | 6 नवमबर 2012 S | 2652364 | 0 | 0 | $0 |
SEC फॉर्म 3/4/5 फाइलिंग से अंदरूनी सूत्र; नेट = केवल ओपन-मार्केट P/S
ईटीएफ स्वामित्व 141 ETFs द्वारा धारित
वजन केवल प्रत्यक्ष इक्विटी होल्डिंग्स (N-PORT) को दर्शाता है; लीवरेज्ड या डेरिवेटिव-आधारित फंड में अतिरिक्त स्वैप एक्सपोजर हो सकता है जो नहीं दिखाया गया है।
| फंड | भार | इकाइयाँ | तिथि अनुसार | स्रोत |
|---|---|---|---|---|
| BUL · Pacer Funds Trust | 5.07% | 16545 NS | 31 जुलाई 2026 | N-PORT |
| IHF · iShares Trust | 4.75% | 147977 SH | 11 सितमबर 2026 | दैनिक |
| STNC · Hennessy Funds Trust | 3.17% | 7315 NS | 31 जुलाई 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 2.45% | 97235 SH | 2 अक्टूबर 2026 | दैनिक |
| COWZ · Pacer Funds Trust | 2.07% | 960711 NS | 31 जुलाई 2026 | N-PORT |
| WLTG · ETF Opportunities Trust | 2.06% | 3942 NS | 31 जुलाई 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.66% | 34083 SH | 2 अक्टूबर 2026 | दैनिक |
| RPG · Invesco Exchange-Traded Fund Trust | 1.27% | 58580 SH | 2 अक्टूबर 2026 | दैनिक |
| FLAG · Global X Funds | 1.14% | 48 NS | 31 जुलाई 2026 | N-PORT |
| FCPI · FIDELITY COVINGTON TRUST | 1.03% | 6909 NS | 31 जुलाई 2026 | N-PORT |
| IYH · iShares Trust | 1.01% | 87417 SH | 11 सितमबर 2026 | दैनिक |
| SRHQ · Elevation Series Trust | 0.94% | 4938 NS | 31 जुलाई 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0.92% | 48109000 SH | 11 सितमबर 2026 | दैनिक |
| FHLC · FIDELITY COVINGTON TRUST | 0.91% | 74445 NS | 31 जुलाई 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.90% | 470451 SH | 19 अगस्त 2026 | दैनिक |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.87% | 22725 NS | 31 जुलाई 2026 | N-PORT |
| DIVB · iShares Trust | 0.87% | 42100 SH | 11 सितमबर 2026 | दैनिक |
| NFRA · FlexShares Trust | 0.84% | 62628 NS | 31 जुलाई 2026 | N-PORT |
| IXJ · iShares Trust | 0.83% | 81708 SH | 11 सितमबर 2026 | दैनिक |
| SPVM · Invesco Exchange-Traded Fund Trust | 0.80% | 2483 SH | 2 अक्टूबर 2026 | दैनिक |
| QUVU · Hartford Funds Exchange-Traded Trust | 0.79% | 3522 NS | 31 जुलाई 2026 | N-PORT |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0.78% | 23458000 | 2 अक्टूबर 2026 | दैनिक |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0.74% | 25897000 | 1 अक्टूबर 2026 | दैनिक |
| CURE · Direxion Shares ETF Trust | 0.72% | 3056 NS | 31 जुलाई 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0.67% | 12075 SH | 19 अगस्त 2026 | दैनिक |
| LGDX · Tidal Trust III | 0.66% | 2345 NS | 31 जुलाई 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0.55% | 11876 SH | 19 अगस्त 2026 | दैनिक |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0.50% | 23126000 | 2 अक्टूबर 2026 | दैनिक |
| LSVD · ADVISORS' INNER CIRCLE FUND | 0.46% | 7404 NS | 31 जुलाई 2026 | N-PORT |
| WLDR · Two Roads Shared Trust | 0.43% | 964 NS | 31 जुलाई 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0.42% | 7289 NS | 31 जुलाई 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.40% | 92161 SH | 2 अक्टूबर 2026 | दैनिक |
| QLC · FlexShares Trust | 0.39% | 9856 NS | 31 जुलाई 2026 | N-PORT |
| XOEF · iShares Trust | 0.37% | 194 SH | 11 सितमबर 2026 | दैनिक |
| GSY · Invesco Actively Managed Exchange-T… | 0.36% | 14000000 | 2 अक्टूबर 2026 | दैनिक |
| UPSD · ETF Series Solutions | 0.33% | 972 NS | 31 जुलाई 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0.33% | 9324000 | 2 अक्टूबर 2026 | दैनिक |
| MGV · VANGUARD WORLD FUND | 0.29% | 97604 SH | 19 अगस्त 2026 | दैनिक |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.28% | 390000 | 2 अक्टूबर 2026 | दैनिक |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.28% | 3186 NS | 31 जुलाई 2026 | N-PORT |
| USXF · iShares Trust | 0.26% | 9226 SH | 11 सितमबर 2026 | दैनिक |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.26% | 5813 SH | 2 अक्टूबर 2026 | दैनिक |
| IWX · iShares Trust | 0.23% | 21535 SH | 11 सितमबर 2026 | दैनिक |
| VTV · VANGUARD INDEX FUNDS | 0.23% | 1475731 SH | 19 अगस्त 2026 | दैनिक |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 14235 NS | 31 जुलाई 2026 | N-PORT |
| MPLY · Strategy Shares | 0.22% | 87 NS | 31 जुलाई 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.21% | 9589 SH | 11 सितमबर 2026 | दैनिक |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 462724 SH | 2 अक्टूबर 2026 | दैनिक |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.20% | 6420 NS | 31 जुलाई 2026 | N-PORT |
| SIZE · iShares Trust | 0.19% | 1920 SH | 11 सितमबर 2026 | दैनिक |
| DYNF · BlackRock ETF Trust | 0.19% | 183934 SH | 11 सितमबर 2026 | दैनिक |
| VMAX · Lattice Strategies Trust | 0.19% | 228 NS | 31 जुलाई 2026 | N-PORT |
| DSI · iShares Trust | 0.19% | 23734 SH | 11 सितमबर 2026 | दैनिक |
| ILCV · iShares Trust | 0.18% | 5870 SH | 10 सितमबर 2026 | दैनिक |
| IVW · iShares Trust | 0.18% | 331185 SH | 11 सितमबर 2026 | दैनिक |
| IUSG · iShares Trust | 0.17% | 136713 SH | 11 सितमबर 2026 | दैनिक |
| VOOG · VANGUARD ADMIRAL FUNDS | 0.17% | 115334 SH | 19 अगस्त 2026 | दैनिक |
| IWD · iShares Trust | 0.17% | 332035 SH | 11 सितमबर 2026 | दैनिक |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.16% | 90157 SH | 19 अगस्त 2026 | दैनिक |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.16% | 17773 SH | 2 अक्टूबर 2026 | दैनिक |
| USMV · iShares Trust | 0.16% | 89855 SH | 11 सितमबर 2026 | दैनिक |
| ACWV · iShares, Inc. | 0.15% | 11903 SH | 11 सितमबर 2026 | दैनिक |
| EGLE · Global X Funds | 0.15% | 8 NS | 31 जुलाई 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0.15% | 4 NS | 31 जुलाई 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0.14% | 33327 SH | 2 अक्टूबर 2026 | दैनिक |
| VOXP · Advisors Series Trust | 0.13% | 18 NS | 31 जुलाई 2026 | N-PORT |
| VRIG · Invesco Actively Managed Exchange-T… | 0.12% | 2250000 | 1 अक्टूबर 2026 | दैनिक |
| TOPC · iShares Trust | 0.12% | 95 SH | 11 सितमबर 2026 | दैनिक |
| DGRO · iShares Trust | 0.12% | 120741 SH | 11 सितमबर 2026 | दैनिक |
| XVV · iShares Trust | 0.11% | 1790 SH | 11 सितमबर 2026 | दैनिक |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.11% | 4410 SH | 2 अक्टूबर 2026 | दैनिक |
| IWL · iShares Trust | 0.11% | 5786 SH | 11 सितमबर 2026 | दैनिक |
| MGC · VANGUARD WORLD FUND | 0.11% | 31176 SH | 19 अगस्त 2026 | दैनिक |
| ACIO · ETF Series Solutions | 0.11% | 6205 NS | 31 जुलाई 2026 | N-PORT |
| EVUS · iShares Trust | 0.10% | 934 SH | 11 सितमबर 2026 | दैनिक |
| ADME · ETF Series Solutions | 0.10% | 751 NS | 31 जुलाई 2026 | N-PORT |
| XRMI · Global X Funds | 0.10% | 126 NS | 31 जुलाई 2026 | N-PORT |
| XCLR · Global X Funds | 0.10% | 9 NS | 31 जुलाई 2026 | N-PORT |
| XYLD · Global X Funds | 0.10% | 8148 NS | 31 जुलाई 2026 | N-PORT |
| XTR · Global X Funds | 0.10% | 12 NS | 31 जुलाई 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.10% | 13621 NS | 31 जुलाई 2026 | N-PORT |
| VV · VANGUARD INDEX FUNDS | 0.10% | 181364 SH | 19 अगस्त 2026 | दैनिक |
| ESGV · VANGUARD WORLD FUND | 0.10% | 33758 SH | 19 अगस्त 2026 | दैनिक |
| IVV · iShares Trust | 0.10% | 1957485 SH | 11 सितमबर 2026 | दैनिक |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0.10% | 26839 SH | 2 अक्टूबर 2026 | दैनिक |
| PTLC · Pacer Funds Trust | 0.10% | 7919 NS | 31 जुलाई 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.10% | 1395 NS | 31 जुलाई 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.10% | 877 SH | 2 अक्टूबर 2026 | दैनिक |
| ILCB · iShares Trust | 0.10% | 2915 SH | 11 सितमबर 2026 | दैनिक |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 1794 SH | 2 अक्टूबर 2026 | दैनिक |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.09% | 20766 NS | 31 जुलाई 2026 | N-PORT |
| IYY · iShares Trust | 0.09% | 6693 SH | 11 सितमबर 2026 | दैनिक |
| VOTE · TCW ETF Trust | 0.09% | 2545 NS | 31 जुलाई 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.09% | 3614 NS | 31 जुलाई 2026 | N-PORT |
| XYLG · Global X Funds | 0.09% | 147 NS | 31 जुलाई 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.09% | 46791 NS | 31 जुलाई 2026 | N-PORT |
| IWB · iShares Trust | 0.09% | 103721 SH | 11 सितमबर 2026 | दैनिक |
| VOO · VANGUARD INDEX FUNDS | 0.09% | 4034357 SH | 19 अगस्त 2026 | दैनिक |
| TOV · EA Series Trust | 0.09% | 607 NS | 31 जुलाई 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0.09% | 586 NS | 31 जुलाई 2026 | N-PORT |
| ITOT · iShares Trust | 0.09% | 202387 SH | 11 सितमबर 2026 | दैनिक |
| ACVF · ETF Opportunities Trust | 0.09% | 337 NS | 31 जुलाई 2026 | N-PORT |
| GTOS · Invesco Actively Managed Exchange-T… | 0.09% | 104000 | 2 अक्टूबर 2026 | दैनिक |
| QDPL · Pacer Funds Trust | 0.09% | 3708 NS | 31 जुलाई 2026 | N-PORT |
| IWV · iShares Trust | 0.09% | 41034 SH | 11 सितमबर 2026 | दैनिक |
| DFAU · Dimensional ETF Trust | 0.08% | 25516 NS | 31 जुलाई 2026 | N-PORT |
| CRBN · iShares Trust | 0.08% | 2269 SH | 11 सितमबर 2026 | दैनिक |
| TOK · iShares Trust | 0.08% | 451 SH | 11 सितमबर 2026 | दैनिक |
| VTI · VANGUARD INDEX FUNDS | 0.08% | 4930930 SH | 19 अगस्त 2026 | दैनिक |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.08% | 24633 SH | 19 अगस्त 2026 | दैनिक |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.08% | 12577 SH | 19 अगस्त 2026 | दैनिक |
| PHDG · Invesco Actively Managed Exchange-T… | 0.08% | 116 SH | 2 अक्टूबर 2026 | दैनिक |
| HCMT · Direxion Shares ETF Trust | 0.08% | 1081 NS | 31 जुलाई 2026 | N-PORT |
| TILT · FlexShares Trust | 0.08% | 4108 NS | 31 जुलाई 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0.07% | 12141 NS | 31 जुलाई 2026 | N-PORT |
| URTH · iShares, Inc. | 0.07% | 14079 SH | 11 सितमबर 2026 | दैनिक |
| ACWI · iShares Trust | 0.06% | 50294 SH | 11 सितमबर 2026 | दैनिक |
| HDUS · Lattice Strategies Trust | 0.05% | 275 NS | 31 जुलाई 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.05% | 125729 SH | 19 अगस्त 2026 | दैनिक |
| DCOR · Dimensional ETF Trust | 0.05% | 3816 NS | 31 जुलाई 2026 | N-PORT |
| GLOF · iShares Trust | 0.04% | 202 SH | 11 सितमबर 2026 | दैनिक |
| DUHP · Dimensional ETF Trust | 0.04% | 10761 NS | 31 जुलाई 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 28662 NS | 31 जुलाई 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.02% | 1127 NS | 31 जुलाई 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 99 NS | 31 जुलाई 2026 | N-PORT |
| GTO · Invesco Actively Managed Exchange-T… | 0.00% | 42000 | 30 सितमबर 2026 | दैनिक |
| CBLS · Elevation Series Trust | -1.12% | -1546 NS | 31 जुलाई 2026 | N-PORT |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 जुलाई 2026 | दैनिक |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 जुलाई 2026 | दैनिक |
| VCEB · VANGUARD WORLD FUND | · | · | 30 जुलाई 2026 | दैनिक |
HCA विश्लेषक सर्वसम्मति तेजी और मंदी के विश्लेषक राय, 12-महीने का मूल्य लक्ष्य, अपसाइड
12-महीने का मूल्य लक्ष्य
22 विश्लेषक · 2026-09-28माध्य लक्ष्य $454.23 +6.5%
सहकर्मी तुलना (GICS उप-उद्योग) प्रमुख मेट्रिक्स बनाम सेक्टर के साथी
वित्तीय वर्ष के आधार पर, प्रत्येक कंपनी के पिछले वित्तीय वर्ष के अंत के बंद भाव के अनुसार कीमतें।
| टिकर | मार्केट कैप | P/E | राजस्व YoY | शुद्ध मार्जिन | ROE | सकल मार्जिन |
|---|---|---|---|---|---|---|
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
| THC | $17.28B | 12.8 | 3.1% | 11.1% | 56.4% | · |
| EHC | $10.61B | 19.2 | 10.5% | 9.5% | 25.1% | · |
| UHS | · | 9.4 | 9.7% | 8.6% | 21.4% | · |
| ENSG | $10.12B | 29.8 | 18.7% | 6.8% | 16.9% | · |
| PACS | $6.01B | 31.5 | 29.3% | 3.6% | 23.1% | · |
| CON | $2.53B | 15.1 | 13.9% | 7.7% | 49.8% | · |
| BKD | $2.57B | -9.6 | 2.2% | -8.2% | -313.2% | 26.2% |
| ACHC | $1.28B | -1.2 | 5.0% | -33.3% | -43.9% | · |
| SNDA | $612M | -7.7 | 25.2% | -18.6% | -197.2% | · |
ताज़ा समाचार इस कंपनी का उल्लेख करने वाली हालिया सुर्खियां
ट्रेडिंग सिग्नल प्रवेश मूल्य और जोखिम/इनाम अनुपात के साथ हालिया खरीद/बिक्री संकेत
अभी कोई खुला सिग्नल नहीं — कोई कार्ड भरा नहीं है, और यह ईमानदार है।
मेरे मेट्रिक्स आपकी व्यक्तिगत वॉचलिस्ट — पूर्ण फंडामेंटल से चयनित पंक्तियाँ
उन मेट्रिक्स को चुनें जो आपके लिए मायने रखते हैं — ऊपर फुल फंडामेंटल्स में किसी भी पंक्ति के बगल में + पर क्लिक करें।
आपका चयन सहेजा गया है और यह सभी टिकर में आपके साथ रहता है।